EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Stimuli‐Responsive Multifunctional Nanomedicine for Enhanced Glioblastoma Chemotherapy Augments Multistage Blood‐to‐Brain Trafficking and Tumor Targeting

Cláudia Martins, Marco Araújo, Alessio Malfanti, Catarina Pacheco, Stuart J Smith, Bernard Ucakar, Ruman Rahman, Jonathan W Aylott, Véronique Préat, Bruno Sarmento iD

Small · 2023

DOI: 10.1002/smll.202300029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2023. Verfasst von Cláudia Martins und 9 weiteren Autor:innen. Beteiligte Einrichtung: i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, Porto, 4200-393, Portugal. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Nanoparticles. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Regional Development Fund, Fundação para a Ciência e a Tecnologia, European Cooperation in Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Minimal therapeutic advances have been achieved over the past two decades for glioblastoma (GBM), which remains an unmet clinical need. Here, hypothesis‐driven stimuli‐responsive nanoparticles (NPs) for docetaxel (DTX) delivery to GBM are reported, with multifunctional features that circumvent insufficient blood‐brain barrier (BBB) trafficking and lack of GBM targeting—two major hurdles for anti‐GBM therapies. NPs are dual‐surface tailored with a i) brain‐targeted acid‐responsive Angiopep‐2 moiety that triggers NP structural rearrangement within BBB endosomal vesicles, and ii) L‐Histidine moiety that provides NP preferential accumulation into GBM cells post‐BBB crossing. In tumor invasive margin patient cells, the stimuli‐responsive multifunctional NPs target GBM cells, enhance cell uptake by 12‐fold, and induce three times higher cytotoxicity in 2D and 3D cell models. Moreover, the in vitro BBB permeability is increased by threefold. A biodistribution in vivo trial confirms a threefold enhancement of NP accumulation into the brain. Last, the in vivo antitumor efficacy is validated in GBM orthotopic models following intratumoral and intravenous administration. Median survival and number of long‐term survivors are increased by 50%. Altogether, a preclinical proof of concept supports these stimuli‐responsive multifunctional NPs as an effective anti‐GBM multistage chemotherapeutic strategy, with ability to respond to multiple fronts of the GBM microenvironment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsNanoparticlesHumansNanomedicineTissue DistributionBrainBlood-Brain BarrierDrug Delivery SystemsCell Line, TumorTumor Microenvironment

Stichwörter der Autor:innen

blood-brain barrierdrug deliverydual-ligand functionalizationglioblastomananomedicinestimuli-responsivenesstargeting

Autor:innen und Institutionen

  • i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, Porto, 4200-393, Portugal.
  • INEB - Instituto Nacional de Engenharia Biomédica, Universidade do Porto, Rua Alfredo Allen 208, Porto, 4200-393, Portugal.
  • ICBAS - Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Rua de Jorge Viterbo Ferreira 228, Porto, 4050-313, Portugal.
  • Advanced Drug Delivery and Biomaterials, Louvain Drug Research Institute, University of Louvain, Brussels, 1200, Belgium.
  • CESPU - Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde, Rua Central de Gandra 1317, Gandra, 4585-116, Portugal.
  • School of Medicine, University of Nottingham Biodiscovery Institute, Children's Brain Tumour Research Centre, University Park, Nottingham, NG7 2RD, UK.

ORCID-Profile: Bruno Sarmento

Förderung

  • European Regional Development Fund
  • Fundação para a Ciência e a Tecnologia
  • European Cooperation in Science and Technology

Zitieren

APA

Martins, C., Araújo, M., Malfanti, A., Pacheco, C., Smith, S. J., Ucakar, B., Rahman, R., Aylott, J. W., Préat, V., & Sarmento, B. (2023). Stimuli‐Responsive Multifunctional Nanomedicine for Enhanced Glioblastoma Chemotherapy Augments Multistage Blood‐to‐Brain Trafficking and Tumor Targeting. Small. https://doi.org/10.1002/smll.202300029

Vancouver

Martins C, Araújo M, Malfanti A, Pacheco C, Smith SJ, Ucakar B, et al. Stimuli‐Responsive Multifunctional Nanomedicine for Enhanced Glioblastoma Chemotherapy Augments Multistage Blood‐to‐Brain Trafficking and Tumor Targeting. Small. 2023. doi:10.1002/smll.202300029

BibTeX
@article{Martins2023,
  author = {Martins, Cláudia and Araújo, Marco and Malfanti, Alessio and Pacheco, Catarina and Smith, Stuart J and Ucakar, Bernard and Rahman, Ruman and Aylott, Jonathan W and Préat, Véronique and Sarmento, Bruno},
  title = {Stimuli‐Responsive Multifunctional Nanomedicine for Enhanced Glioblastoma Chemotherapy Augments Multistage Blood‐to‐Brain Trafficking and Tumor Targeting},
  journal = {Small},
  year = {2023},
  doi = {10.1002/smll.202300029}
}
Kostenlos starten →